
TSE:MFC
This summary was created by AI, based on 28 opinions in the last 12 months.
Manulife Financial (MFC) has received mixed reviews from experts, highlighting its strengths in capital management, particularly in Asia and wealth management. Several analysts view it as a reliable income stock, benefiting from a decent dividend yield, yet caution against its growth potential compared to Canadian banks. The company has faced short-term challenges, including mixed results from its alternative portfolio and limited growth in its U.S. operations, which has sparked some concerns. Analysts suggest waiting for opportunities to buy during pullbacks, given its valuation relative to major financials, alongside the potential for increased profitability stemming from rising interest rates. Overall, while MFC is generally recognized for its stability and improvements in earnings quality, it struggles to capture investor attention amidst recent market shifts.
Have been doing very well and have turned the ship around, but he is not happy that 35% of their actual earnings are coming out of the Orient, mainly China. He gets nervous about companies that have a lot of money coming from foreign sources. Would rather that people make their money in Europe or North America.
TSX Financials are beginning to peak. This is a component of that group. The 3-year comparison chart, between this and the financials, showed that the company started to close the gap in 2012, and ran close together in 2013-2014. A one-year view showed that it was quite choppy from January to April, and Manulife broke down below the TSX financials and is starting to work lower. Be cautious.
Rotate out of this and into TD (TD-T)? He wouldn't. Because the banks have had such a wonderful move here, he expects there will be some catch up out of the lifecos. If you can see the Asian market improving, and he does, this company has a big exposure there. It should catch up in the next few quarters, and he thinks the banks will more or less go sideways. He owns both.
All lifecos had a pretty good year last year, but have pulled back this year. They’ve kind of underperformed the financial services space. Valuations got a bit ahead of themselves. These companies typically do better when bond rates are rising. Rates have pulled back. On her Watch List. She sees better earnings and dividend growth momentum from Canadian banks.
They are levered to rising interest rates and stock prices. The move down in rates is going to hurt them in the next quarter but he is looking for a rise in interest rates longer term. Likes their global footprint and how they are growing. Would put them at the top of the list and you may want to start adding insurance companies back shortly.
Had a pullback as bond yields continue to drift lower. Although bond yields may drift a little bit lower, she thinks they are going to turn around as we move into the back half of this year. The last couple of quarters have had decent growth in core earnings. On track to meet their 2016 target. The Asian business provides a good platform. Wealth management is a pretty big piece of about 40% of the underlying operating earnings. Yield of 2.59%.
Sensitive to higher interest rates so is definitely coming down a little bit with rates migrating lower. Bear in mind that insurance companies takes a lot of the premiums and have to deploy them so if they have to go into a lower interest rate environment, their underlying profitability is less. A dividend increase is not too, too far away. Sees good momentum in their John Hancock operations in the US. Also, have a good beachhead in Japan. Good Hold for the next 12-18 months.